Anti-retroviral Therapy
Showing 1 - 25 of >10,000
Human Immunodeficiency Virus Trial in Pietermaritzburg (START Together)
Active, not recruiting
- Human Immunodeficiency Virus
- START Together
-
Pietermaritzburg, KwaZulu-Natal, South AfricaHuman Sciences Research Council
Nov 9, 2022
In Utero Drug Exposure Trial in Mthatha (Pregnant HIV positive women on ARTs, Babies born to HIV positive mothers on ARTs)
Not yet recruiting
- In Utero Drug Exposure
- Pregnant HIV positive women on ARTs
- Babies born to HIV positive mothers on ARTs
-
Mthatha, Eastern Cape, South AfricaUmtata General Hospital
May 3, 2021
Smoking, Smoking Cessation, HIV Trial in Miami (Nicoderm C-Q Transdermal Product, Adherence to Antiretroviral Therapy
Completed
- Smoking
- +2 more
- Nicoderm C-Q Transdermal Product
- +4 more
-
Miami, FloridaUniversity of Miami
Nov 5, 2021
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Active, not recruiting
- Human Immunodeficiency Virus
- +6 more
- Anti-HIV Agents
-
Lusaka, ZambiaCentre for Infectious Disease Research in Zambia (CIDRZ)
Jun 1, 2022
HIV Trial in San Diego (Digital Health Feedback System)
Active, not recruiting
- HIV
- Digital Health Feedback System
-
San Diego, California
- +1 more
Dec 21, 2022
Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)
Active, not recruiting
- Malignant Neoplasm
- aldesleukin
- +7 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles (UCLA )
Dec 1, 2022
HIV/AIDS Trial in San Diego (Digital Health Feedback System(DHFS))
Active, not recruiting
- HIV/AIDS
- Digital Health Feedback System(DHFS)
-
San Diego, CaliforniaUCSD AntiViral Research Center
Aug 23, 2021
Human Immunodeficiency Virus Trial (YBank program)
Completed
- Human Immunodeficiency Virus
- YBank program
- (no location specified)
Aug 25, 2020
Early Anti-Retroviral Treatment in HIV- Infected Children
Active, not recruiting
- HIV Infections
- Blood samples collection
-
Bamako, Mali
- +5 more
Mar 13, 2023
Substance Abuse Among Anti-retroviral Treatment Naive Patients
Completed
- HIV Infections
- Substance like alcohol, marijuana, etc.
-
Khagaria, Bihar, IndiaART centre, Sadar Hospital
Mar 16, 2022
Hiv Trial
Not yet recruiting
- Hiv
- (no location specified)
Apr 19, 2023
The Visceral Adiposity Measurement and Observation Study
Recruiting
- HIV
- +18 more
- Diagnostic Test
- HIV Anti-retroviral Background Therapy
-
Los Angeles, California
- +5 more
Sep 21, 2022
HIV-1 Infection Trial in Berlin (MK-8583)
Completed
- HIV-1 Infection
-
Berlin, GermanyCharite Research Organisation GmbH ( Site 0001)
Feb 14, 2020
Retroviral Insertion Site Analysis in Strimvelis Gene Therapy
Enrolling by invitation
- Severe Combined Immunodeficiency Due to ADA Deficiency
- Retroviral Insertion Site Analysis
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Feb 17, 2022
HIV-1 Infection Trial in Berlin (MK-4250)
Completed
- HIV-1 Infection
-
Berlin, GermanyCharite Research Organisation GmbH ( Site 0001)
Oct 7, 2019
HIV, Inpatient Facility Diagnoses Trial (Team Based Inpatient ARTAS, Standard of Care)
Not yet recruiting
- HIV Infections
- Inpatient Facility Diagnoses
- Team Based Inpatient ARTAS
- Standard of Care
- (no location specified)
May 18, 2023
HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)
Active, not recruiting
- HIV-1-infection
- Switch to B/F/TAF
- Continue current regimen
-
Kisumu, Kenya
- +1 more
May 24, 2022
HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)
Recruiting
- HIV-1-infection
- +2 more
- ASC22 1mg/kg
- +3 more
-
Beijing, Beijing, ChinaThe FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022
Accurate Staging of Immuno-virological Dynamics During Acute HIV
Recruiting
- HIV
- Seroconversion, HIV
- Early combination anti-retroviral treatment
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Oct 27, 2021
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023